Nous sommes désolés. Le contenu de cette page n'est présentement disponible qu'en anglais.
Scam warning
If you have received an email with my name in the signature block (but originating from an email address other than @blg.com) that suggests that you take urgent action to preserve your trademark rights -- it is not from me and it is not legitimate.
Read more in this advisory from the College of Patent and Trademark Agents, and this advisory from the Canadian Intellectual Property Office.
David’s intellectual property practice focuses on obtaining, evaluating and advising on patent protection. He is regularly involved in obtaining patent protection on behalf of corporate, government and academic clients in the life sciences and manufacturing sectors.
David’s areas of expertise include:
patent applications related to biotechnology, life sciences, pharmaceuticals, therapeutics, medical devices, chemistry, and oil and gas
patentability, validity, infringement and freedom-to-operate issues
international patent strategies and portfolio management
After graduate school, David worked in Ottawa at the Children’s Hospital of Eastern Ontario as a research associate and at a start-up biotechnology company. He has conducted research in the areas of synthetic organic chemistry, cell surface remodelling, and molecular and cellular biology.
David fournit des services juridiques par l’intermédiaire d’une société professionnelle.
Expérience
Experience
Drafted and prosecuted patent applications related to:
anti-cancer viruses
insect pheromone compositions
chemical catalysts
water treatment systems
solid phase micro-extraction
glycopeptide compositions
glass microparticle compositions
Examples include:
European Patent No. 2 510 088 (“Oncolytic Rhabdovirus”)
European Patent No. 2 718 427 (“Compositions for Glioblastoma treatment”)
European Patent No. 3 061 345 (“Sex pheromone derivatives, and methods and uses thereof”)
PCT Application No. CA2016/050622 (“Ligand for catalyst or pre-catalyst and method of forming C(sp2)-N bond”)
PCT Application No. CA2018/051078 (“Chiral catalyst and method for asymmetric reduction of an imine”)
U.S. Patent No. 9,783,443 (“Treatment of water to extend half-life of ozone”)
PCT Application No.s CA2015/050551, CA2015/050550, CA2017/050279, and CA2017/050562 (all related to solid phase micro-extraction)
Managed global patent portfolios related to:
vaccine formulation and development
devices for micro-extraction of biological analytes
water treatment systems
anti-cancer viruses
delivery and detection of embolic particles
Drafted and prosecuted patent applications related to:
anti-cancer viruses
insect pheromone compositions
chemical catalysts
water treatment systems
solid phase micro-extraction
glycopeptide compositions
glass microparticle compositions
Examples include:
European Patent No. 2 510 088 (“Oncolytic Rhabdovirus”)
European Patent No. 2 718 427 (“Compositions for Glioblastoma treatment”)
European Patent No. 3 061 345 (“Sex pheromone derivatives, and methods and uses thereof”)
PCT Application No. CA2016/050622 (“Ligand for catalyst or pre-catalyst and method of forming C(sp2)-N bond”)
PCT Application No. CA2018/051078 (“Chiral catalyst and method for asymmetric reduction of an imine”)
U.S. Patent No. 9,783,443 (“Treatment of water to extend half-life of ozone”)
PCT Application No.s CA2015/050551, CA2015/050550, CA2017/050279, and CA2017/050562 (all related to solid phase micro-extraction)
Managed global patent portfolios related to:
vaccine formulation and development
devices for micro-extraction of biological analytes
Co-Author, “Get a Competitive Advantage through Patent Database Mining,” Renewable Energy and Cleantech Canada, 2011.
Publication
Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd Edition, Borden Ladner Gervais LLP, 2011
Publication
Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd edition, Borden Ladner Gervais LLP, 2011.
Publication
Nauman & Bertozzi, “Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting,” Biochim Biophys Acta, 2001, 1568(2):147-54.
Publication
Jacobs, Nauman, et al., “Metabolic labeling of glycoproteins with chemical tags through unnatural sialic acid biosynthesis,” Methods in Enzymology, 2000, 327:260-75.
Beyond Our Walls
Professional Involvement
Member, Intellectual Property Institute of Canada (IPIC)
Member, joint liaison committee between patent branch management and IPIC patent agents
Awards & Recognitions
Recognized in the 2024 (and since 2016) in the IAM Patent 1000 — The World's Leading Patent Practitioners (Patent Prosecution)
Recognized as a patent leader for Canada in the 2022 and 2023 editions of IAM Global Leaders
Education
Registered Canadian Patent Agent, 2009
Registered U.S. Patent Agent for Canadian applicants, 2009
PhD (organic chemistry),
University of California, Berkeley, 2002
BSc (chemical engineering),
Massachusetts Institute of Technology, 1997
